Zhong Guo Xin Wen Wang·2025-06-30 13:35Core Points - The signing of the National Natural Science Foundation's Private Enterprise Innovation Development Joint Fund marks a significant step for private enterprises in China to engage deeply in national basic research [1][3] - Four private enterprises, including Jiangsu Hengrui Medicine Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hangzhou Xiehe Medical Supplies Co., Ltd., and Qilu Pharmaceutical Co., Ltd., have officially joined the fund [1][3] Group 1 - The National Natural Science Foundation Committee emphasizes the critical role of private enterprises in technological innovation and overcoming challenges such as technological blockades and insufficient original innovation capabilities [3][4] - The joint fund aims to attract high-level scientific forces to participate in basic research in the medical field, enhancing independent innovation capabilities and supporting national medical safety and transformation [3][4] Group 2 - The four signing private enterprises plan to focus on cutting-edge areas such as tumor immunology and new delivery systems, promoting innovation from target discovery to clinical transformation [3] - They will collaborate with universities to tackle core components of medical imaging equipment, accelerating the localization of high-end medical devices [3] - The enterprises will support basic research in biomedical materials, aiming to break through key technologies such as absorbable materials and high-precision detection [3][4]